What is the correct albendazole syrup dose and administration for a 2‑year‑old child weighing 10–12 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Albendazole Syrup Dosing for a 2-Year-Old Child (10–12 kg)

For a 2-year-old child weighing 10–12 kg, administer albendazole 400 mg as a single oral dose for common soil-transmitted helminth infections (hookworm, ascariasis, enterobiasis). 1

Standard Dosing Regimen

  • Single-dose therapy: Albendazole 400 mg given once is the standard treatment for children ≥24 months with common parasitic infections including hookworm, Ascaris lumbricoides, Trichuris trichiura, and Enterobius vermicularis (pinworm). 1

  • Administration: Give albendazole with food to improve absorption, particularly with fatty meals for enhanced bioavailability. 2, 3

  • Formulation: Albendazole is available as oral suspension (syrup), which is ideal for young children who cannot swallow tablets. 3

Age-Specific Considerations

  • Children aged 12–24 months can receive albendazole when local epidemiology justifies treatment, though the evidence base is most robust for children >24 months. 1

  • At 2 years of age (24 months), this child falls into the well-supported age range for standard 400 mg single-dose therapy. 1

Infection-Specific Dosing Variations

For most common helminths (single-dose regimen):

  • Ascaris lumbricoides: 400 mg single dose achieves 98–100% cure rate. 4, 5
  • Hookworm: 400 mg single dose achieves 88–98% cure rate. 4, 5
  • Enterobius vermicularis (pinworm): 400 mg single dose. 1

For infections requiring extended therapy:

  • Strongyloidiasis: 400 mg once daily for 3 consecutive days; consider repeat course at 8 weeks to eradicate larvae that mature into adults. 1
  • Taenia species (tapeworm): 400 mg once daily for 3 days per WHO recommendations. 1
  • Trichuris trichiura (whipworm): Single 400 mg dose has limited efficacy (cure rate 27–63%); consider 400 mg daily for 3 days or alternative therapy if this is the primary target. 4, 5, 6

Important Safety Considerations

  • Do not use in children <12 months unless treating a life-threatening infection under specialist supervision. 1

  • Monitoring for prolonged therapy: If treatment extends beyond 14 days (rare in routine practice), monitor for hepatotoxicity and leukopenia. 2

  • Combination therapy caution: If considering albendazole plus ivermectin for empirical treatment of eosinophilia, first exclude Loa loa infection in children with travel to endemic regions to avoid severe adverse events. 1

Follow-Up Recommendations

  • Repeat dosing: For certain helminths like Strongyloides or schistosomiasis, a repeat treatment at 8 weeks may be necessary because immature stages are relatively resistant to single-dose therapy. 1

  • Treatment failure: If symptoms persist or reinfection is suspected, repeat stool examination and consider extended regimens (3-day courses) or alternative agents, particularly for T. trichiura which responds poorly to single-dose albendazole. 6, 7

Clinical Pearls

  • Single-dose albendazole 400 mg is highly effective for Ascaris (>95% cure rate expected) and hookworm (>90% cure rate expected), but substantially less effective for Trichuris (50–65% cure rate). 5, 7

  • The weight-based dosing of 15 mg/kg/day divided twice daily (maximum 800 mg/day) is reserved for specific conditions like hydatid disease or neurocysticercosis requiring prolonged therapy, not for routine helminth treatment. 3

  • For this 10–12 kg child with routine soil-transmitted helminths, the flat 400 mg single dose is appropriate and does not require weight-based calculation. 1, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.